Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Clinical trial NCT07626411 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07626411
- Sponsor
- Regeneron Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-09-11
- Enrollment
- 15364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.